INVO Fertility, Inc. Revenue from Contract with Customer, Including Assessed Tax
INVO Fertility, Inc. (IVF) reported Revenue from Contract with Customer, Including Assessed Tax of $61.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-16.
Discontinued › Income Statement
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2019-04-16
- INVO Fertility, Inc. revenue from contract with customer, including assessed tax for fiscal 2018 was $61.00K.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|
| 2018-12-31 | $61.00K 10-K · filed 2019-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |